Showing 21 - 40 results of 2,085 for search '"Viral hepatitis"', query time: 0.09s Refine Results
  1. 21

    EFFECT BY INTESTINAL MICROBIOM ON THE PROGRESSION OF VIRAL HEPATITIS by N. N. Polishchuk, A. M. Kamyshny

    Published 2017-01-01
    “…This review displays current understanding of the intestinal microbiome impacting on the progression of chronic viral hepatitis caused by HCV- and HBV-infection, as well as changes in bowel microbiocenosis features depending on the duration of chronic process in the liver. …”
    Get full text
    Article
  2. 22
  3. 23

    Thyrotoxic Periodic Paralysis Precipitated by Viral Hepatitis by Ronak Patel, Sanchit Uppal, Abhinav Meelu, Mini Bhatnagar

    Published 2023-03-01
    “…She was diagnosed to have hepatic failure due to viral hepatitis A. Her serum potassium level was 1.79 mmol/L. …”
    Get full text
    Article
  4. 24
  5. 25
  6. 26
  7. 27

    Viral Hepatitis in Patients with Inflammatory Bowel Disease by Seung Hwan Shin, Sang Hyoung Park

    Published 2022-08-01
    “…In this review article, we have summarized the latest evidence on viral hepatitis in patients with IBD that would be of assistance in clinical practice. …”
    Get full text
    Article
  8. 28

    Pancreatitis Associated with Viral Hepatitis: Systematic Review by Nikola Panic, Sladjana Mihajlovic, Miroslav Vujasinovic, Milutin Bulajic, Johannes-Matthias Löhr

    Published 2020-10-01
    “…Conclusion: Increased awareness of pancreatic involvement in viral hepatitis is needed because it can have a substantial impact on therapeutic approaches and outcomes.…”
    Get full text
    Article
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33
  14. 34

    Sonographic changes of liver and gallbladder in acute viral hepatitis by Ebrahimi Daryani N, Ghenaati M, Moosavi M

    Published 2001-07-01
    “…Hepatomegaly, decrease in the liver paranchymal echo and increase in the gallbladder wall thickness has been shown in acute viral hepatitis. The present study was done to determine sonographic changes in acute viral hepatitis. …”
    Get full text
    Article
  15. 35

    Hemophilia Patients’ Level of Knowledge of About Viral Hepatitis by Hüsnü PULLUKÇU, Meltem Işıkgöz TAŞBAKAN, Arzu Nazlı ZEKA, Tansu YAMAZHAN, Raika DURUSOY, Fahri ŞAHİN, Güray SAYDAM

    Published 2016-12-01
    “…As a consequence, hemophilia patients are under high risk of many transfusion-borne infections, especially viral hepatitis and human immunodeficiency virus infection. …”
    Get full text
    Article
  16. 36

    Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma by Laura Marinela Ailioaie, Gerhard Litscher

    Published 2020-09-01
    “…Blue laser light and UltraBioavailable Curcumin could be a new valuable alternative for medical applications in chronic B viral hepatitis and hepatocarcinoma, saving millions of lives.…”
    Get full text
    Article
  17. 37

    Alaninaminotransferase and specific viral hepatitis markers in the blood of donors by Zh. K. Burkitbayev, G. A. Yesenbayeva, S. A. Abdrakhmanova, Zh. Zh. Bibekov, Ye. B. Zhiburt

    Published 2018-08-01
    “…To study the dynamics of viral hepatitis detection rate after implementation of donors preliminary testing for alanine aminotransferase (ALT) activity. …”
    Get full text
    Article
  18. 38
  19. 39

    Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences by Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger

    Published 2022-03-01
    “…Chronic viral hepatitis is a main cause of liver disease and hepatocellular carcinoma. …”
    Get full text
    Article
  20. 40

    Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis by Yi-Wen Huang, Albert Qin, Chan-Yen Tsai, Pei-Jer Chen

    Published 2022-05-01
    “…Ropeginterferon alfa-2b has demonstrated efficacy and showed a favorable safety profile for the treatment of chronic viral hepatitis in several clinical studies. In this article, we review its pharmacokinetics and available clinical data and suggest that ropeginterferon alfa-2b administered once every two weeks can serve as a new treatment option for patients with chronic viral hepatitis, including chronic hepatitis B, C, and D.…”
    Get full text
    Article